<--- Back to Details
First PageDocument Content
Pharmaceutics / Pharmaceuticals policy / Food and Drug Administration / Therapeutics / Drug Master File / Abbreviated New Drug Application / Generic drug / New Drug Application / Pharmaceutical drug / Pharmaceutical industry / Pharmaceutical sciences / Pharmacology
Pharmaceutics
Pharmaceuticals policy
Food and Drug Administration
Therapeutics
Drug Master File
Abbreviated New Drug Application
Generic drug
New Drug Application
Pharmaceutical drug
Pharmaceutical industry
Pharmaceutical sciences
Pharmacology

Microsoft Word - GDUFA Statutory Language[removed]docx

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 536,40 KB

Share Document on Facebook

Similar Documents

Seminars on Drug Discovery & Development Wednesdays 17::00, Lecture Hall 1, Pharmazentrum, Klingelbergstrasse 50, Basel Feb 24, 16 Prof. Dr. G. Klebe, Institute of Pharmaceutical Chemistry, Philipps-University Mar

DocID: 1vnYL - View Document

Send Orders of Reprints at 614 Current Pharmaceutical Design, 2013, 19, Rejuvenating Sirtuins: The Rise of a New Family of Cancer Drug Targets

DocID: 1v1vA - View Document

eclipse | RBM data sheet Risk Based Monitoring (RBM) Drug costs are soaring. The pharmaceutical, biotech and CRO industries are more competitive than ever before. Companies like yours are looking for ways to reduce expe

DocID: 1uZyk - View Document

2nd APV Conference on “Highly Potent Drug Products in the Pharmaceutical Industry” 26 to 27 September 2018 Mannheim, Germany

DocID: 1utU5 - View Document

AIDS Treatment Activists Coalition (ATAC) Pharmaceutical Company HIV/AIDS Report Card Issued by the ATAC Drug Development Committee September 10, 2009

DocID: 1u8Vg - View Document